Define the intended format
Clarify the oral dosage form and the experience you want to create before reviewing formulation platforms.
Bioziel Group
Preparing your experienceMove from active ingredient to tablet trials with Advantol 300, a ready-to-use excipient system for dry blending and compression. Evaluate it against your active, equipment and target dosage form.
Science in service of your next step.
Review the product in the context of your intended application. Our team can help frame a focused technical conversation.
Clarify the oral dosage form and the experience you want to create before reviewing formulation platforms.
Consider loading, compatibility and the processing needs of the active within the complete formulation.
Identify the questions around tablet integrity, disintegration and sensory properties that your trials need to address.
Request the technical documents relevant to your material, application and evaluation requirements.
Explore formulation platforms for orally disintegrating, dispersible and other oral dosage forms. Bring active-ingredient compatibility, tablet performance and ease of use into the same development conversation.
Explore detailsAddress taste as part of your development strategy. Explore taste-masked materials and consider the interaction between sensory performance, active-ingredient characteristics and release requirements.
Explore detailsExplore ingredients and formulation platforms for orally disintegrating tablets and powders. Review disintegration, tablet integrity and mouthfeel alongside the characteristics of your active ingredient.
Explore details


Tell us about your application. We’ll help you identify the material options and information worth exploring.
Start a conversation